Most people who have metastatic breast cancer first had an early stage breast cancer that was followed by a distant recurrence. Metastatic breast cancer must be treated on an individualized basis: The treatment should be continued as long as its benefits for the individual patient outweigh its adverse side effects. At first, every ache or pain can frighten you. Proc Am Soc Clin Oncol 26, abstr. The American Journal of Managed Care. Less certain is the role that lifestyle factors such as diet and weight play in recurrence, although some studies suggest that obesity is associated with the survival and persistence of cancer cells after treatment. They often have free factsheets and booklets they can send to you.
Breast Cancer Recurrence Risk Lingers Years After Treatment Ends
At present, there are four clinical situations Box 4. Risk of recurrence after surgery and additional treatments After surgery for breast cancer your doctor will look at the risk that the cancer will come back recur to decide if you should be offered additional treatments called adjuvant therapy. Despite the considerable scientific data and many successes in treating breast cancer, not much is known about recurrent breast tumors, other than that they can appear in almost any location in the body and at any time after remission is attained—even decades later. Available treatments Currently licensed treatment options have been greatly expanded in recent years box 3. Open in a separate window. Locoregional recurrence Local disease recurrence Box 2 is generally treated curatively 9.
Recurrent Breast Cancer
Press Member of the press? Get honest information, the latest research, and support for you or a loved one with breast cancer right to your inbox. The treatment you have for a local recurrence depends on the treatment you had before. If breast cancer comes back in a reconstructed breast, your doctor may recommend that the implant or skin flap used to rebuild the breast be removed. Breast Cancer Res Treat.
In other words, an estrogen receptor positive breast cancer is just as likely to recur in the period 13 years to 14 years after diagnosis as it is between the third and fourth year out. Lack of radiation following a partial mastectomy can increase the risk of local recurrence. Eur J Cardiothorac Surg. Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer. Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancer.